Insights

Research, Insights, and Evidence

An Evidence-Based, Behavioral Approach to
Behavior Change

2Morrow's programs are based on a wealth of research from around the world that looks at using concepts from Acceptance and Commitment Therapy, or ACT, to help people change their lives for the better. ACT is a third-wave Cognitive Behavioral Therapy (CBT) model that is especially helpful in dealing with unhelpful or unpleasant thoughts, feelings, or urges. This offers new hope for helping people change health behaviors and improve coping skills and resilience. There are over 300 randomized control trials published on Acceptance and Commitment in a variety of focus areas.

Current programs are available in 2Morrow Health, our digital coaching platform. Research has been done on this tech/approach under other names including: iCanQuit, SmartQuit, 2Morrow Quit.

2Morrow Research Collaborations

2Morrow works with some of the top minds in ACT research and practice. From developing content and reviewing programs to collaborating on clinical research, evidence-based practice is part of our DNA.

2Morrow has participated in 8+ clinical trials on 2Morrows core programs/platform. Typical outcomes include improvements in mood, impact and valued action.

Madigan Army Medical Center logo with text and emblem.
University of New Mexico logo with maroon and gray colors
The logo of Trinity College Dublin and The University of Dublin.
Seattle Children's Hospital logo with a blue circle and a white stylized child figure inside
Fred Hutch logo with a stylized globe and the text 'Fred Hutch Cures Start Here'.

Smoking Cessation Research on 2Morrow's Programs

Press Release

Large Randomized Clinical Trial Validates 2Morrow's Digital Health Approach to Behavioral-modification and Proves that Apps can Help Smokers Quit

Read Press Release
“This is a landmark study that fast-forwards the field of digital health, including its critical application during the COVID-19 pandemic helping people who smoke quit. The Fred Hutch researchers meticulously recruited and engaged a diverse sample of smokers, successfully retaining over 85% of those for 12 months. The size of the quitting effect and the difference between the ACT app and the comparison app was similar to effects seen in successful drug trials, providing very compelling evidence that using this app will help people quit smoking.”
— Dr. Tim McAfee, MD, MPH, Former Director, Office of Smoking & Health, CDC.

Chronic Pain

2Morrow was Awarded $1.9 Million NIH Grant to Develop a Digital Health Program for People Living with Chronic Pain

2Morrow, an industry leader in providing evidence-based, digital health solutions focused on ACT-Based behavioral interventions for chronic conditions, has been awarded a $1.9 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant.

Phase 1: Study results: Developing Digital Therapeutics for Chronic Pain in Primary Care: A Qualitative Human-Centered Design Study of Providers’ Motivations and Challenges

Phase 2: RCT starts in July 2023. Research partner: UW Medicine

The Body of Evidence

There are over 20 randomized control trials on ACT strategies for Chronic Pain and the APA gives its highest rating for STRONG RESEARCH SUPPORT.

  • Vowles, Kevin E - 2017-2018 Completed: Study at UMN looking at 2Morrow's Chronic Pain Program, Vowles, K. Funded by an LSDF grant. n=26

  • Other ACT for Pain Research

UW Medicine logo in black text.

Weight Management

  • There are over a dozen randomized control trials on weight, eating disorders and related topics (plus other data)

  • State of the ACT Evidence (links to over 300 studies, papers and more)

  • 2017-2018: App-based Weight program study. A single arm, pilot trial of 2Morrow's ACT-based weight program. Conducted with overweight adults that are part of an Army Medical Center primary care population. Research Partner: Family Medicine Residency, Joint Base Lewis-McChord.

  • Dallal, D.H. & Forman, E.M. (2019, Nov.). Can an acceptance-based smartphone application for weight loss promote change in ACT-based mechanistic processes? Poster to be presented at the Behavioral Medicine and Integrated Primary Care Special Interest Group Exposition at the 53rd Annual Convention of the Association for Behavioral and Cognitive Therapies, Atlanta, GA.

Stress, Mood, & Anxiety

  • There are over two dozen randomized control trials on ACT for Stress and Anxiety

  • State of the ACT Evidence (links to over 200 studies, papers and more)

Other ACT Research and Information

Financial Conflict of Interest Policy

2Morrow’s Financial Conflict of Interest (FCOI) Policy describes certain legal obligations applicable to Investigators’ disclosure of potential financial conflicts of interest. The purpose of this policy is to comply with applicable law and to ensure the objectivity of the research conducted by 2Morrow, its employees, contractors, and consultants. Access the full policy here.

“2Morrow is one of the few mobile health companies that recognize that effective mhealth interventions require the integration of behavioral science and technology. Their applications start with the premise that simply receiving basic education and a way to keep a log of behavioral changes is not enough to produce long-lasting and meaningful change. In fact, 2Morrow apps teach sophisticated psychological strategies and specialized skills that are key to making impactful behavioral changes, modifying one’s lifestyle and improving quality of life. Moreover, they take into account that chronic health problems often come with depression and anxiety that must also be addressed.”
— Dr. Evan Foman, PhD. Behavioral Scientist at Drexel University